E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer (Q73126787)
Jump to navigation
Jump to search
scientific article published on 01 February 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer |
scientific article published on 01 February 2003 |
Statements
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer (English)
Kathy D Miller